Gastroduodenal motility

Current Opinion in Gastroenterology

Volumn 26, Issue 6, 2010, Pages 647-655

  Tack, Jan ^a   Janssen, Pieter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

brain gut axis; duodenal acid exposure; duodenal inflammation; gastric electrical stimulation; gastric motility; gastroprokinetic drugs; visceral sensitivity

Indexed keywords

ACOTIAMIDE; BOTULINUM TOXIN; GSK 962040; HERBACEOUS AGENT; IBEROGAST; N [2 (DIISOPROPYLAMINO)ETHYL] 2 (2 HYDROXY 4,5 DIMETHOXYBENZAMIDO) 4 THIAZOLECARBOXAMIDE; PROKINETIC AGENT; R 137696; SEROTONIN 1A AGONIST; SEROTONIN 4 AGONIST; TZP 101; UNCLASSIFIED DRUG; VELUSETRAG;

CONSTIPATION; DEVICE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DUODENITIS; DYSPEPSIA; ELECTROSTIMULATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; ILEUS; INTESTINE MOTILITY; MONITORING; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SENSITIVITY ANALYSIS; SENSORIMOTOR FUNCTION; STOMACH PARESIS;

DYSPEPSIA; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS; INTESTINES; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTORS, GHRELIN; SENSATION; SEROTONIN 5-HT4 RECEPTOR AGONISTS; STOMACH;

EID: 77958514651     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32833ece1e     Document Type: Review

References (72)

1. Parkman HP, Camilleri M, Farrugia G, et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2010; 22:113-133.
2. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466-1479.
3. Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136:1225-1233.
4. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Thjodleifsson B. Natural history of functional dyspepsia: a 10-year population-based study. Digestion 2010; 81:53-61.
5. Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 2009; 21:378-388.
6. Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009; 137:94-100.
7. Zagari RM, LawGR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastro enterology 2010; 138:1302-1311.
8. Manabe N, Haruma K, Hata J, et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol 2010; 45:567-572.
9. Janssen P, Vos R, Tack J. Influence of citalopram on interdigestive gastrointestinal motility in man. Aliment Pharmacol Ther 2010; 32:289-295.
10. Ameloot K, Janssen P, Scarpellini E, et al. Endocannabinoid control of gastric sensorimotor function in man. Aliment Pharmacol Ther 2010; 31:1123-1131.
11. Parkman HP, Jones MP. Tests of gastric neuromuscular function. Gastroenterology 2009; 136:1526-1543.
12. Tack J. Mandatory and optional function tests in gastroduodenal disorders. Best Pract Res Clin Gastroenterol 2009; 23:387-393.
13. Ziessman HA, Okolo PI, Mullin GE, Chander A. Liquid gastric emptying is often abnormal when solid emptying is normal. J Clin Gastroenterol 2009; 43:639-643.
14. Maqbool S, Parkman HP, Friedenberg FK. Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit. Dig Dis Sci 2009; 54:2167-2174.
15. Kloetzer L, Chey WD, McCallum RW, et al. Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil 2010; 22:527-533; e117.
16. Khayyam U, Sachdeva P, Gomez J, et al. Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil 2010; 22:539-545.
17. Kindt S, Dubois D, Van Oudenhove L, et al. Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil 2009; 21:1183-e105.
18. Cherian D, Sachdeva P, Fisher RS, Parkman HP. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol 2010; 8:676-681.
19. Coleski R, Hasler WL Coupling and propagation of normal and dysrhythmic gastric slow waves during acute hyperglycaemia in healthy humans. Neurogastroenterol Motil 2009; 21:492-499; e1-e2.
20. Sha W, Pasricha PJ, Chen JD. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol 2009; 43:716-722.
21. Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci 2010; 55:359-370.
22. LinZ, SarosiekI, ForsterJ, et al. Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis. Neurogastroenterol Motil 2010; 22:56-61; e1 0.
23. Tack J, Jones MP, Karamanolis G, et al. Symptom pattern and pathophysiological correlates of weight loss in tertiary-refer red functional dyspepsia. Neurogastroenterol Motil 2010; 22:29-35; e4-e5.
24. Lee KJ, Demarchi B, Demedts I, et al. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 2004; 99:1765-1773.
25. Ishii M, Manabe N, Kusunoki H, et al. Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy. J Gastroenterol 2008; 43:935-941.
26. Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol 2009; 43:527-533.
27. di Stefano M, Vos R, Vanuytsel T, et al. Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers. Neurogastroenterol Motil 2009; 21:e712-e740.
28. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55:327-333.
29. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22:847-853.
30. Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and nonerosive reflux disease. Digestion 2009; 79:65-72.
31. Lee KJ, Cha DY, Cheon SJ, et al. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion 2009; 80:58-63.
32. Borg J, Melander O, Johansson L, et al. Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia. BMC Gastroenterol 2009; 9:17.
33. Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129:98-104.
34. Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosino-philia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009; 29:765-773.
35. Walker MM, Salehian SS, Murray CE, et al. Implications of eosinophilia in the normal duodenal biopsy: an association with allergy and functional dyspepsia. Aliment Pharmacol Ther 2010; 31:1229-1236.
36. Kindt S, Tertychnyy A, de Hertogh G, et al. Intestinal immune activation in presumed postinfectious functional dyspepsia. Neurogastroenterol Motil 2009; 21:e832-e856.
37. Futagami S, Shindo T, Kawagoe T, et al. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol 2010; 105:1835-1842.
38. KindtS, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21:389-398.
39. Dizdar V, Spiller R, Singh G, et al. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31:883-891.
40. Gathaiya N, Locke GR 3rd, Camilleri M, et al. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009; 21:e922-e969.
41. Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004; 126:971-979.
42. OshimaT, NakajimaS, YokoyamaT, et al. The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet 2010; 11:13.
43. Tahara T, Arisawa T, Shibata T, et al. Serotonin-2A receptor gene T102C polymorphism in patients with dyspeptic symptoms. Hepatogastroenterology 2008; 55:1921-1924.
44. Tahara T, Arisawa T, Shibata T, et al. 779 TC of CCK-1 intron 1 is associated with postprandial syndrome (PDS) in Japanese male subjects. Hepatogastroenterology 2009; 56:1245-1248.
45. Camilleri M, Carlson P, Zinsmeister AR, et al. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol 2009; 296: G510-G516.
46. Quick C, Kliem A, Berger S, et al. Gastric dysmotility in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34:92-97.
47. Van Oudenhove L, Vandenberghe J, Dupont P, et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol 2010; 105:913-924.
48. Van Oudenhove L, Vandenberghe J, Dupont P, et al. Regional brain activity in functional dyspepsia: A H(2)(15)O-PET study on the role of gastric sensitivity and abuse history. Gastroenterology 2010; 139:36-47.
49. TackJ. Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol 2008; 8:690-696.
50. Manini ML, Camilleri M, Goldberg M, et al. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil 2010; 22:42-49; e7-e8.
51. Suzuki H, HibiT. Acotiamide (Z-338) as a possible candidate forthe treatment of functional dyspepsia. Neurogastroenterol Motil 2010; 22:595-599.
52. Seto K, Sasaki T, Katsunuma K, et al. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil 2008; 20:1051-1059.
53. TackJ, Masclee A, Heading R, et al. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil 2009; 21:272-280.
54. Matsueda K, Hongo M, TackJ, et al. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia-100mg t.i.d. is an optimal dosage. Neurogastroenterol Motil 2010; 22:618-e173.
55. Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2010; 55:675-683.
56. Sanger GJ, Westaway SM, Barnes AA, et al. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility. Neurogastroenterol Motil 2009; 21:657-664; e30-e31.
57. Falken Y, Hellstrom PM, Sanger GJ, et al. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol Motil 2010; 22:e192-e200.
58. Ang D, Nicolai H, Vos R, et al. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man. Neurogastroenterol Motil 2009; 21:528-533; e8-e9.
59. Ejskjaer N, Vestergaard ET, Hellstrom PM, et al. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and sympto matic gastroparesis. Aliment Pharmacol Ther 2009; 29:1179-1187.
60. Ejskjaer N, Dimcevski G, Wo J, et al. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil 2010. [Epub ahead of print]
61. Reddymasu SC, Singh S, Sankula R, et al. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis. Am J Med Sci 2009; 337:161-164.
62. Bai Y, Xu MJ, Yang X, et al. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion 2010; 81:27-34.
63. Van Oudenhove L, Kindt S, Vos R, et al. Influence of buspirone on gastric sensorimotor function in man. Aliment Pharmacol Ther 2008; 28:1326-1333.
64. Miwa H, Nagahara A, Tominaga K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspep sia: a randomized controlled trial. Am J Gastroenterol 2009; 104:2779-2787.
65. Boeckxstaens GE, Tytgat GN, Wajs E, et al. The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol Motil 2006; 18:919-926.
66. Tack J, Van Den Elzen B, Tytgat G, et al. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Neurogastroenterol Motil 2009; 21:619-626; e23-e24.
67. Rosch W, Liebregts T, Gundermann KJ, et al. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 2006; 13 (Suppl 5):114-121.
68. Braden B, Caspary W, Borner N, et al. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil 2009; 21:632-638; e25.
69. McCallum RW, Snape W, Brody F, et al. Gastric electrical stimulation with Enterra improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010. [Epub ahead of print]
70. McCallum RW, Dusing RW, Sarosiek I, et al. Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients. Neurogastroenterol Motil 2010; 22:161-167; e50-e51
71. Erratum in Neurogastroenterol Motil 2010; 22:491.
72. Andersson S, Elfvin A, RingstromG, et al. A slow caloric satiety drinking test in patients with temporary and permanent gastric electrical stimulation. Eur J Gastroenterol Hepatol 2010;22:926-932.